Cardiovascular Risk in Children With Chronic Conditions Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-01

Study Completion Date

2029-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children living with chronic health conditions face a higher risk of developing cardiovascular diseases than their peers, largely due to the accelerated aging of the heart and blood vessels. Although experts recognize this elevated risk and recommend close monitoring and early intervention, the underlying mechanisms driving this phenomenon remain poorly understood. At present, no effective interventions specifically target its root causes.

Recent research shows that both large blood vessels (such as the carotid artery) and small vessels (such as those in the retina) can display early signs of damage decades before clinically apparent heart or vascular disease emerges. This accelerated vascular aging can result from multiple factors - including disease-related processes such as persistent inflammation and metabolic disturbances, treatment-related effects such as chemotherapy or long-term steroid use, and lifestyle changes associated with chronic illness, such as reduced physical activity and altered eating habits. However, it is still unclear how these factors influence the development and progression of vascular changes in children as they grow. Importantly, these changes can be monitored through non-invasive methods, offering a unique opportunity to study at-risk patients many years before overt cardiovascular disease develops.

Identifying these early changes may enable us to detect and track individuals at heightened risk well in advance of clinical disease. This study aims to deepen our understanding of the causes of increased cardiovascular risk in children with chronic conditions and to lay the groundwork for earlier, more targeted prevention strategies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Factors for CV Disease in a Dialysis Cohort

NCT00006297

Cardiovascular Diseases Heart Diseases Atherosclerosis +1 more

COMPLETED

Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project

NCT06083168

Chronic Kidney Disease Cardiovascular Diseases

RECRUITING

Coronary Artery Risk Development in Young Adults

NCT00005130

Cardiovascular Diseases Coronary Disease Hypertension +3 more

ACTIVE_NOT_RECRUITING

Complement and Cardiovascular Risk in Adolescents

NCT02821104

Cardiovascular Disease Type 2 Diabetes

COMPLETED

Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?

NCT01536808

Type 2 Diabetes Mellitus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Transplant Familial Hypercholesterolaemia Type 1 Diabetes Mellitus (T1DM) Type 2 Diabetes Mellitus (T2DM) Chronic Kidney Disease Kawasaki Disease Liver Transplant Obesity and Overweight Hypertension Coarctation of Aorta Bone Marrow Transplant Cancer (Solid Tumors) Leukemia Lymphoma Lipoprotein(a) Aorta Stenosis Non Alcoholic Fatty Liver Disease Dyslipaemia White Coat Hypertension Pulmonary Hypertension Juvenile Idiopahtic Arthritis Systemic Lupus Erthematosus Inflammatory Bowel Disease (IBD) HIV Infection Transposition of Great Arteries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Individuals aged between 6 and 25 years;
2. Diagnosed with a chronic childhood condition/disease associated with an increased risk of early cardiovascular disease;
3. Provided informed consent (if over 18 years old) or had informed consent provided by their legal guardian (if under 18 years old) following appropriate information about the study.

Chronic childhood conditions/diseases associated with increased risk of early cardiovascular disease are defined according to the 2019 American Heart Association recommendations (https://doi.org/10.1161/CIR.0000000000000618), as well as other conditions/diseases for which at least two large-scale epidemiological studies have demonstrated an increased risk of cardiovascular disease.

Exclusion Criteria

1. Severe intellectual and developmental disability;
2. Decompensated heart failure;
3. Severe primary immunodeficiency;
4. Ongoing intravenous chemotherapy;
5. Infectious diseases posing a public health risk; or
6. History of regular alcohol or drug use.

Minimum Eligible Age

6 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No